Page 23 - Genentech Access Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech access solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Access Solutions Today - Breaking & Trending Today

Documentation of asthma remission endpoints varies

SAN DIEGO — Few patients are evaluated based on all seven endpoints of guidelines indicating complete asthma remission, according to a poster presented at the American Thoracic Society International Meeting. Standardized protocols that include all these domains are needed for accurate assessment of asthma remission, Thomas C. Corbridge, MD, FCCP, U.S. senior medical lead, respiratory ....

United States , San Diego , Kristen Dowd , Byrichard Gawel , Thomasc Corbridge , American Thoracic Society International Meeting , American Thoracic Society , Teva Pharmaceutical , American College Of Asthma , American Thoracic Society International Conference , American Academy Of Asthma , American Thoracic Society International , American Academy , American College , Mayo Clinic , Asthma Control Test ,

First Aflibercept Biosimilars Approved in US

The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). (aflibercept). However, patent litigation has left it unclear when the biosimilars will come to market. ....

United States , Samsung Bioepis , Biocon Biologics Yesafili , Biocon Biologics , Cardinal Health , European Commission , European Union , Syda Productions , United Kingdom ,

Health care professionals celebrate 'milestone' FDA approval for HER2-positive solid tumors

An analysis of global online conversations among health care professionals on social media in April revealed tremendous enthusiasm about FDA approval of a treatment for adults with advanced HER2-positive solid tumors. The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu; AstraZeneca, Daiichi Sankyo) — a HER2-directed antibody-drug conjugate previously approved ....

United States , Davidr Gandara , David Cooke , Davis Healthdescribing , Sarah Sammons , Joaquim Bellmunt , Daiichi Sankyo , Marka Lewis , Vivek Subbiah , Lank Center , Sarah Cannon Research Institute , Dana Farber Cancer Institute , Genitourinary Oncology At Dana Farber Cancer Institute , Uc Davis Health , American College Of Cardiology , Genitourinary Oncology , Mayo Clinic , Bacillus Calmette Guerin , Intermountain Healthcare , American College ,